贝伐单抗
医学
伊立替康
中性粒细胞减少症
内科学
不利影响
外科
相伴的
胃肠病学
化疗
癌症
结直肠癌
作者
Henry S. Friedman,Michael D. Prados,Patrick Y. Wen,Tom Mikkelsen,David Schiff,Lauren E. Abrey,W.K. Alfred Yung,Nina A. Paleologos,M. Kelly Nicholas,Randy L. Jensen,James J. Vredenburgh,Jane Huang,Maoxia Zheng,Timothy F. Cloughesy
摘要
We evaluated the efficacy of bevacizumab, alone and in combination with irinotecan, in patients with recurrent glioblastoma in a phase II, multicenter, open-label, noncomparative trial.
科研通智能强力驱动
Strongly Powered by AbleSci AI